ChemoCentryx
CCXI
#3711
Rank
HK$29.28 B
Marketcap
HK$407.12
Share price
0.00%
Change (1 day)
34.97%
Change (1 year)

Market capitalization of ChemoCentryx (CCXI.defunct)

Last known market cap: HK$29.28 Billion

On November 25, 2022 ChemoCentryx had a market cap of HK$29.28 Billion. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of ChemoCentryx from 2012 to 2022

End of year Market Cap

Year Marketcap Change
2022HK$29.21 B46.94%
2021HK$19.88 B-40.15%
2020HK$33.22 B79.06%
2019HK$18.55 B328.74%
2018HK$4.32 B90.89%
2017HK$2.26 B-17.36%
2016HK$2.74 B-1.11%
2015HK$2.77 B20.52%
2014HK$2.30 B19.53%
2013HK$1.92 B-37.54%
2012HK$3.08 B

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Johnson & Johnson
JNJ
HK$4.270 T 14,484.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
HK$1.204 T 4,014.40%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
HK$2.831 T 9,571.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
HK$1.463 T 4,897.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
HK$217.91 B 644.25%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
HK$2.181 T 7,350.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
HK$951.23 B 3,148.72%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
HK$878.53 B 2,900.46%๐Ÿ‡ฌ๐Ÿ‡ง UK
Teva Pharmaceutical Industries
TEVA
HK$293.57 B 902.63%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel